MELISSA BARBER: Open Payments
NPI 1275099657 · OPELOUSAS, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,846 in 166 payments from 18 companies in 2025. Trend: 2023 $2,953 · 2024 $2,609 · 2025 $3,846
Food & beverage: $3,846
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 18 | $725 |
| GlaxoSmithKline, LLC. | 34 | $617 |
| AstraZeneca Pharmaceuticals LP | 21 | $542 |
| Regeneron Healthcare Solutions, Inc. | 22 | $510 |
| Verona Pharma, Inc. | 10 | $267 |
| Viatris Specialty LLC | 20 | $240 |
| Baxter Healthcare | 10 | $156 |
| Janssen Pharmaceuticals, Inc | 1 | $150 |
| Grifols USA, LLC | 5 | $108 |
| Insmed, Inc. | 6 | $102 |
Products named: DUPIXENT, NUCALA, Ohtuvayre, FASENRA, YUPELRI, TRELEGY ELLIPTA, Hillrom - Vest System Model 105 Home Care, BREZTRI.
Industry payments across LA — which companies pay providers there.
